Ziprasidone in the Psychosis Prodrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary
Calgary, Alberta, Canada
- University of California at San Diego
La Jolla, California, United States
- University of California at Los Angeles
Los Angeles, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Emory University
Atlanta, Georgia, United States
- Beth Israel Deaconess Hospital
Boston, Massachusetts, United States
- University of Massachusetts
Worcester, Massachusetts, United States
- Wayne State University School of Medicine
Detroit, Michigan, United States
- North Shore, Long Island Jewish Health System
Glen Oaks, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2008
- Primary completion
- 30 Nov 2012
- Completion
- 30 Nov 2012
- Last update posted
- 27 Mar 2023
- Registered enrollment
- 51
- Registry id
- NCT00635700
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.